Aligos Therapeutics Inc
(NAS:ALGS)
$
0.4557
0.0349 (8.39%)
Market Cap: 35.59 Mil
Enterprise Value: -66.66 Mil
PE Ratio: 0
PB Ratio: 0.60
GF Score: 45/100 - Aligos Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Aligos Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 15, 2023
- Aligos Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Aligos Therapeutics Inc ALGS Going Public TranscriptOct 16, 2020
Aligos Therapeutics Inc ALGS Going Public Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)